The reduction of body weight and fat mass exerted by CB1 antagonists in diet-induced obesity models is partially due to the counteraction of a peripheral stimulation of lipogenesis by endocannabinoids (Di Marzo and Matias, 2005). This evidence concerns the gene CNR1 and obesity due to melanocortin 4 receptor deficiency.